CardiaPill®
Cardiovascular Disease Prevention/Treatment
Not Disclosed (Likely Pre-clinical/Early Clinical)Active
Key Facts
Indication
Cardiovascular Disease Prevention/Treatment
Phase
Not Disclosed (Likely Pre-clinical/Early Clinical)
Status
Active
Company
About CardioPharma
CardioPharma is a private, pre-revenue biotech company targeting the global cardiovascular disease epidemic with its patented polypill platform. Founded in 2003 and based in San Diego, the company's strategy centers on improving medication adherence—a major issue in CVD management—by consolidating multiple essential drugs into a single, convenient daily dose. Its lead asset, CardiaPill®, is protected by a key US patent and several international grants, with a patent term extending to 2039, providing a long runway for development and commercialization. The company is led by seasoned pharmaceutical executives and is pursuing global regulatory pathways for its pipeline.
View full company profile